Saturday, March 14, 2020

(robbering folder)

and ending war today! another weekend, saturday, 12.45 pm! Imagine so..we hv an universal ID RFID card...as computing science imagine, that would be stricly necessary..and here it si. For any doubs read the code bar numbers the first 5 to undesratnd it



at No comments:

(robbering folder) OK. Plan is! 1st jamming their surveillance gps antenna and mobile communication on the block. 2nd Already hve RFID ID's copy remotely, to go inside disguised and 3rd electromagnetic pulse. Stll trying to find for sale "plasma vortex" it exists its on the market. (what you see in the movies, bla bla chinese gear..is just plasma vortex)

at No comments:

robbering folder, heis ---major equippment RFID card copy reader remotely

gd morning, welcome back to war, another weekend, saturday, 10.30 am! Back to the heist! So, I hv 2 new features for u guys! Any of our "projects" already discussed have a crucial need , ID cards, we can't except to robb ID's, so best alternative (and next post) remote rfid reader, that must be installed on the area, major issue, the price!
technical designation : Applied Wireless AWID Lr-3000-b-u Lr-3000 White Long Range Reader
Gosto

at No comments:

Wednesday, March 11, 2020

corona virus (terrorism folder)

so...back to war, wedensady, 14.25 pm.
Let's get a sample of Covid 19...you need a saliva sample, and this kit. If you want to proceed to atypical uncurable pneumonia, you might use it also

QIAGEN.COM
QIAamp Viral RNA Mini Kit - QIAGEN Online Shop
For isolation of viral RNA from cell-free body fluids
at No comments:

corona virus

gd morning, welcome back to war, wednesday, 09.15 am
"The regulator had previously set a Feb. 4, 2020, target date for a decision on the Alnylam drug."
"The first RNAi drug, Alnylam Pharmaceuticals’ Onpattro (patisiran), was FDA-approved last August and it is showing long-term efficacy and sustained treatment for the rare disease hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). In addition to its fully stocked pipeline, Alnylam now has its eyes set on the next possible FDA approval, with the FDA granting priority review to their investigational RNAi drug for the rare disease acute hepatic porphyria, givosiran"
Comentários
  • Elsinha David One way to alter protein production via RNA is using RNA interference (RNAi), where a small strand of RNA acts as the biological drug by binding to mRNA in a cell and preventing it’s translation into a protein. This process effectively knocks down the mRNA so that no protein is produced. Since RNAi was the topic of the 2006 Nobel Prize in Physiology or Medicine,
  • Elsinha David Givosiran employs a gene-silencing technique called RNA interference (RNAi). Alnylam says its drug reduces to near-normal levels the toxic enzymes that prompt AHP attacks
  • Elsinha David What's the issues, the Lab scientistcs talk Google ...
  • Elsinha David FDA still afraid of the toxity
  • Elsinha David price for this...700 euros not less for commercial purposes Mark
  • Elsinha David this means ...make the accounting, on a small country, 10 million citzens, 7 billion
  • Elsinha David the PIB of 3 years is not enough

at No comments:

Tuesday, March 10, 2020

corona virus


Sonovia’s ultrasonic fabric-finishing technology, invented by two Bar-Ilan University chemistry professors, mechanically infuses antiviral, antimicrobial zinc and copper oxide nanoparticles into textiles for facemasks and other protective products.
Sonovia recently received a European Commission Horizon 2020 grant and the technology has won several prizes in China.
Two Israeli companies are rushing to complete development of facemasks that could be vital prevention tools in epidemics like Wuhan coronavirus.
ISRAEL21C.ORG
New antiviral masks from Israel may help stop deadly coronavirus - ISRAEL21c
Two Israeli companies are rushing to complete development of facemasks that could be vital prevention tools in epidemics like Wuhan coronavirus.
at No comments:

corona virus medication cure

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

Severe acute respiratory syndrome (SARS) is caused by a newly discovered coronavirus (SARS-CoV). No effective prophylactic or post-exposure therapy is currently available. We report, however, that chloroquine has strong antiviral effects on SARS-CoV infection of primate cells. These inhibitory effects are observed when the cells are treated with the drug either before or after exposure to the virus, suggesting both prophylactic and therapeutic advantage. In addition to the well-known functions of chloroquine such as elevations of endosomal pH, the drug appears to interfere with terminal glycosylation of the cellular receptor, angiotensin-converting enzyme 2. This may negatively influence the virus-receptor binding and abrogate the infection, with further ramifications by the elevation of vesicular pH, resulting in the inhibition of infection and spread of SARS CoV at clinically admissible concentrations. Chloroquine is effective in preventing the spread of SARS CoV in cell culture. Favorable inhibition of virus spread was observed when the cells were either treated with chloroquine prior to or after SARS CoV infection. In addition, the indirect immunofluorescence assay described herein represents a simple and rapid method for screening SARS-CoV antiviral compounds.

Chloroquine Tablets

FROM £5.99
https://www.simpleonlinepharmacy.co.uk/online-doctor/malaria-tablets/chloroquine/

Medication features

  • Used for malaria prevention
  • Once a week dosage
  • Continue for 4 weeks after leaving the zone

at No comments:
Subscribe to: Posts (Atom)